HIVERA is an ERA-Net action devoted to HIV/AIDS research throughout Europe and coordinated by the French national agency for research on AIDS and on viral hepatitis (ANRS). It involves ministries, research organisations, and governmental bodies, funding agencies from Belgium, Estonia, Germany, Italy, Portugal, Romania, and Hungary.
The main objective of HIVERA is the establishment of European-wide joint funding programmes on HIV/AIDS research. HIVERA aims at harmonizing and vitalizing HIV/AIDS research policies across Europe with high standards in programme management and in scientific evaluation.
Consortia funded under the auspices of HIVERA with Portuguese participation
Consortium: VIHDUAVAX – A combination of two gp41 peptides for a new prophylactic vaccine both neutralizing HIV-1 and inhibiting CD4 depletion,
Coordinator: Patrice Debré, Hôpital La Pitié Salpêtrière, França
Portuguese researcher: José Marcelino, Institute of Hygiene and Tropical Medicine, Nova University of Lisbon
Consortium: DELIN – An innovative approach to deliver dual-targeting HIV entry inhibitors using cationic liposomes
Portuguese researcher and coordinator: Miguel Castanho, Institute of Molecular Medicine, School of Medicine, University of Lisbon
Consortium: BEST HOPE - Bio-Molecular and Epidemiological Surveillance of HIV Transmission Patterns, Transmitted Drug Resistance, Hepatitis Co-infections, and Ongoing Aging Processes in Europe
Coordinator: Osama Hamouda, Robert Koch Institute, Berlin, Germany
Portuguese researcher: Ana Abecassis, Institute of Hygiene and Tropical Medicine, Nova University of Lisbon